Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05801029
Title A Study to Investigate Safety and Efficacy of Osimertinib and Amivantamab in Participants With Non-small Cell Lung Cancer With Common Epidermal Growth Factor Receptor Mutations (OSTARA)
Acronym OSTARA
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors AstraZeneca
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | CAN

Facility Status City State Zip Country Details
Research Site WITHDRAWN Beverly Hills California 90211 United States Details
Research Site WITHDRAWN Glendale California 91206 United States Details
Research Site WITHDRAWN Sacramento California 95817 United States Details
Research Site WITHDRAWN Washington District of Columbia 20007 United States Details
Research Site WITHDRAWN New York New York 10016 United States Details
Research Site WITHDRAWN Fairfax Virginia 22031 United States Details
Research Site WITHDRAWN Edmonton Alberta T6G 1Z2 Canada Details
Research Site WITHDRAWN Newmarket Ontario L3Y 2P9 Canada Details
Research Site WITHDRAWN Thunder Bay Ontario P7B 6V4 Canada Details
Research Site WITHDRAWN Montreal Quebec H3G 1A4 Canada Details
Research Site WITHDRAWN Montreal Quebec H3T 1M5 Canada Details
Research Site RECRUITING Hong Kong 150001 Hong Kong Details
Research Site RECRUITING Hong Kong HKG Hong Kong Details
Research Site RECRUITING Hong Kong Hong Kong Details
Research Site RECRUITING Shatin 00000 Hong Kong Details
Research Site RECRUITING Anyang-si 14068 Korea, Republic of Details
Research Site RECRUITING Busan 49241 Korea, Republic of Details
Research Site RECRUITING Daegu 42415 Korea, Republic of Details
Research Site RECRUITING Daejeon 35015 Korea, Republic of Details
Research Site RECRUITING Gwangju 61469 Korea, Republic of Details
Research Site RECRUITING Seoul 08308 Korea, Republic of Details
Research Site RECRUITING Seoul 5030 Korea, Republic of Details
Research Site RECRUITING George Town 10990 Malaysia Details
Research Site RECRUITING Kota Bharu 15586 Malaysia Details
Research Site RECRUITING Kuala Lumpur 50586 Malaysia Details
Research Site RECRUITING Kuala Lumpur 59100 Malaysia Details
Research Site RECRUITING Kuantan 25100 Malaysia Details
Research Site RECRUITING Kuching 93200 Malaysia Details
Research Site RECRUITING Singapore 169610 Singapore Details
Research Site RECRUITING Singapore 188770 Singapore Details
Research Site RECRUITING Singapore 308433 Singapore Details
Research Site RECRUITING Kaohsiung 82445 Taiwan Details
Research Site RECRUITING Kaohsiung 833 Taiwan Details
Research Site RECRUITING Taichung 404 Taiwan Details
Research Site RECRUITING Taichung 40705 Taiwan Details
Research Site RECRUITING Tainan 73657 Taiwan Details
Research Site RECRUITING Taipei City 110 Taiwan Details
Research Site RECRUITING Taipei 10048 Taiwan Details
Research Site NOT_YET_RECRUITING Taipei 11217 Taiwan Details
Research Site RECRUITING Yunlin 640 Taiwan Details
Research Site RECRUITING Bangkok 10330 Thailand Details
Research Site RECRUITING Bangkok 10400 Thailand Details
Research Site RECRUITING Bangkok 10700 Thailand Details
Research Site RECRUITING Chiang Mai 50200 Thailand Details
Research Site RECRUITING Songkhla 90110 Thailand Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field